The present invention relates to a carbonic acid adduct (CAA) comprising carbonic acid, at least one amine, and optionally at least one salt, said adduct being producible by a method comprising the following steps: a) providing a solution (A) comprising dissolved CO.sub.2; optionally b) dissolving a base (BA) not corresponding to the amine (AM) in the solution (A) so as to obtain the solution (A1); c) dissolving the at least one amine (AM) in the solution (A) or (A1) so as to obtain the solution (B); d) freezing the solution obtained after completion of step c); and e) storing the solution frozen in step d) at −100 to 0° C. for no longer than 4 days. The content of CO.sub.2 in the solution that is subjected to step c) is at least 6 g/l. The invention also relates to a method for producing the carbonic acid adduct (CAA), a pharmaceutical preparation (PP) comprising the carbonic acid adduct (CAA), and methods for the production thereof and use of the carbonic acid adduct (CAA) or the pharmaceutical preparation (PP) in therapy for a range of indications.

The present invention relates to a carbonic acid adduct (CAA) comprising carbonic acid, at least one amine, and optionally at least one salt, said adduct being producible by a method comprising the following steps: a) providing a solution (A) comprising dissolved CO.sub.2; optionally b) dissolving a base (BA) not corresponding to the amine (AM) in the solution (A) so as to obtain the solution (A1); c) dissolving the at least one amine (AM) in the solution (A) or (A1) so as to obtain the solution (B); d) freezing the solution obtained after completion of step c); and e) storing the solution frozen in step d) at −100 to 0° C. for no longer than 4 days. The content of CO.sub.2 in the solution that is subjected to step c) is at least 6 g/l. The invention also relates to a method for producing the carbonic acid adduct (CAA), a pharmaceutical preparation (PP) comprising the carbonic acid adduct (CAA), and methods for the production thereof and use of the carbonic acid adduct (CAA) or the pharmaceutical preparation (PP) in therapy for a range of indications.

Disclosed is a non-destructive universal method of functionalization of graphitic carbonaceous materials that enables their alignment, cross-linking, and effective integration into composite materials.

Disclosed is a non-destructive universal method of functionalization of graphitic carbonaceous materials that enables their alignment, cross-linking, and effective integration into composite materials.

Pulverulent compositions of a complex between an acid and a metal form an at least partially spherical particle. The acid is selected from 2-hydroxy-4-methyl-thiobutanoic acid (HMTBA), methionine, aspartic acid, the alginic acids, the pectinic acids, and the corresponding anions, in particular 2-hydroxy-4-methyl-thiobutanoate, methioninate, aspartate, the alginates and the pectinates. The metal is divalent or trivalent. The particle has an amorphous fraction the mass of which represents at least 50% of the total mass of the particle. The particle is substantially devoid of uncomplexed acid or anion and of uncomplexed metal or metal cation.

Pulverulent compositions of a complex between an acid and a metal form an at least partially spherical particle. The acid is selected from 2-hydroxy-4-methyl-thiobutanoic acid (HMTBA), methionine, aspartic acid, the alginic acids, the pectinic acids, and the corresponding anions, in particular 2-hydroxy-4-methyl-thiobutanoate, methioninate, aspartate, the alginates and the pectinates. The metal is divalent or trivalent. The particle has an amorphous fraction the mass of which represents at least 50% of the total mass of the particle. The particle is substantially devoid of uncomplexed acid or anion and of uncomplexed metal or metal cation.

The present invention relates to a modifier represented by Formula 1, a method of preparing the same, a modified conjugated diene-based polymer having a high modification ratio which includes a modifier-derived functional group, and a method of preparing the polymer.

The present invention relates to a modifier represented by Formula 1, a method of preparing the same, a modified conjugated diene-based polymer having a high modification ratio which includes a modifier-derived functional group, and a method of preparing the polymer.

Process of ortho-halogenation of phenylalanine compounds by C—H activation.

Process of ortho-halogenation of phenylalanine compounds by C—H activation.